(Q47998272)

7 February 2018

http://europepmc.org/abstract/MED/27650634

title

Tolerance and effectiveness of nivolumab after pediatric T-cell replete, haploidentical, bone marrow transplantation: A case report (English)

1 reference

7 February 2018

http://europepmc.org/abstract/MED/27650634

author

Jeffrey Huo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Aziza T Shad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Courtney Darcy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Amal Abu-Ghosh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Giuseppe Esposito

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Mary-Jo Holuba

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Nancy Robey

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Kenneth R Cooke

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Heather J Symons

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Allen R Chen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Nicolas J Llosa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

21 September 2016

1 reference

7 February 2018

http://europepmc.org/abstract/MED/27650634

published in

Pediatric Blood Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27650634%20AND%20SRC:MED&resulttype=core&format=json

Modern approaches to HLA-haploidentical blood or marrow transplantation

1 June 2020

cites work

1 reference

Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

21 January 2018

1 reference

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

21 January 2018

1 reference

Immune checkpoint blockade: a common denominator approach to cancer therapy

21 January 2018

1 reference

Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality

21 January 2018

1 reference

Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism

21 January 2018

1 reference

Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031

21 January 2018

1 reference

Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).

21 January 2018

1 reference

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

21 January 2018

1 reference